Welcome to the international HTA database

Showing [23806 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	HAYES, Inc.	High-frequency chest wall compression for diseases other than cystic fibrosis
2014	HAYES, Inc.	Plasma exchange for treatment of steroid-refractory transverse myelitis
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	[The effect of infection control interventions in day-care facilities and schools]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Patient-controlled analgesia for management of acute sickle cell disease
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Botulinum toxin type A for prophylactic treatment of chronic migraine
2014	HAYES, Inc.	Intrathecal opioids for chronic noncancer pain
2014	NIHR Health Technology Assessment programme	Allopurinol for the treatment of chronic kidney disease: a systematic review
2014	HAYES, Inc.	Zio Patch (iRhythm Technologies Inc.) for long-term ambulatory cardiac rhythm monitoring
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	[Effects of more than three months organized follow-up on physical activity and diet for people with increased risk of lifestyle related disease]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	BMI reduction and chronic disease management: clinical evidence
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Safety of renal biopsy for patients taking aspirin
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Psychological interventions to improve poor oral health in adults and adolescents
2014	NIHR Health Technology Assessment programme	Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men
2014	HAYES, Inc.	Intravenous immunoglobulin for rheumatic diseases
2014	NIHR Health Technology Assessment programme	United Kingdom Oscillation Study: long-term outcomes of a randomised trial of two modes of neonatal ventilation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Risk factors for high resource utilization in patients with sickle cell disease
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Invasive ventilation in patients with Amyotrophic Lateral Sclerosis and respiratory failure
2014	NIHR Health Technology Assessment programme	VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model
2014	Agency for Healthcare Research and Quality (AHRQ)	Pharmacologic therapies for the management of Crohn's disease: comparative effectiveness
2014	HAYES, Inc.	Intravenous vitamin C for the treatment of cancer
2014	NIHR Health Technology Assessment programme	Death, Bereavement and randomised controlled trials (BRACELET): a methodological study of policy and practice in neonatal and paediatric intensive care trials
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suspended ceiling lifts: safety
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Sequencing of urinalysis and urine culture in catheterized patients with suspected urinary tract infection
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Surgical or endovascular intervention for aortic coarctation in adult native, residual or re-coarctation?
2014	NIHR Health Technology Assessment programme	A randomised controlled trial and cost-effectiveness evaluation of booster interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods
2014	HAYES, Inc.	Percutaneous mitral valve repair
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	OnabotulinumtoxinA (Botox - Allergan Inc.) indication: chronic migraine
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Sustainability of inpatient psychiatric rehabilitation for adults: systematic review]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014	Penn Medicine Center for Evidence-based Practice (CEP)	Allocating nursing personnel across units: shift-to-shift staffing
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Intravenous immunoglobulin for post-polio syndrome
2014	Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)	[Evaluation of measures related to the prevention of multiple falls in hospitalized elderly people]
2014	NIHR Health Technology Assessment programme	Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014	HAYES, Inc.	Positron Emission Tomography (PET) for metastatic melanoma
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	The use of teledermatology and teledermoscopy for referrals of patients with suspected skin cancer
2014	NIHR Health Technology Assessment programme	Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study
2014	HAYES, Inc.	Robotically assisted hysterectomy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Endobronchial valves in emphysema]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Miethke proSA® adjustable gravitational shunt for hydrocephalus
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality
2014	HAYES, Inc.	Sensory integration therapy for non-autistic children
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Implantation of a permanent embolic protection in patients with non-valvular attrial fibrillation in left auricular appendage]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014	HAYES, Inc.	Smoking cessation in patients with schizophrenia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Stereotactic radiofrequency / SRFA SRFA in hepatocellular carcinoma and liver metastases]
2014	NIHR Health Technology Assessment programme	KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014	HAYES, Inc.	The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Hyperthermic intraperitoneal chemotherapy]
2014	NIHR Health Services and Delivery Research programme	A cross-sectional prevalence survey of psychotropic medication prescribing patterns in prisons in England
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014	HAYES, Inc.	Transcranial direct current stimulation for depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral intake in critical care patients: guidelines and recommendations
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous transluminal angioplasty (pta) with drug eluting stents in peripheral arterial disease, upper limb and thorax]
2014	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Islet transplantation in patients with Type 1 Diabetes Mellitus
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014	HAYES, Inc.	Transcranial magnetic stimulation for treatment-resistant depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014	NIHR Health Technology Assessment programme	Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review
2014	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Excimer laser atherectomy for uncrossable coronary lesions and improperly deployed coronary stents
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014	NIHR Health Technology Assessment programme	A systematic review of the effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
2014	HAYES, Inc.	Transcranial Magnetic Stimulation (TMS) to enhance pharmacotherapy for depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Options for developing a web-based forum on patient registries
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014	NIHR Health Technology Assessment programme	Systematic review to identify and appraise outcome measures used to evaluate childhood obesity treatment interventions (CoOR): evidence of purpose, application, validity, reliability and sensitivity
2014	HAYES, Inc.	Afirma thyroid FNA analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	KRAS testing for metastatic colorectal cancer using therascreen KRAS RGQ PCR kit
2014	Agency for Healthcare Research and Quality (AHRQ)	Transition care for children with special health needs
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naloxone prescribing: guidelines
2014	HAYES, Inc.	ERCC1 expression analysis in Non-Small Cell Lung Cancer (NSCLC)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aclidinium bromide (Tudorza Genuair - Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014	Agency for Healthcare Research and Quality (AHRQ)	Outcome measure framework design document
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014	HAYES, Inc.	HERmark breast cancer assay
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Safety of vaccines used for routine immunization in the United States
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Slow-release opioids for postoperative pain: clinical effectiveness
2014	HAYES, Inc.	Immunoglobulin gene testing for B-cell leukemia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Antidepressant treatment of depression during pregnancy and the postpartum period
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014	NIHR Health Technology Assessment programme	Vitamin D supplementation in pregnancy: a systematic review
2014	HAYES, Inc.	L1 syndrome (L1CAM-related disorders)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bivalirudin infusion following angioplasty: safety
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for advance care planning